Talk
Talk by Dr Arijit Patra
Title: The world of non-clinical safety, artificial intelligence, and foundation models
Abstract:
There has been a significant amount of interest in artificial intelligence in the pharmaceutical industry, particularly with respect to drug discovery. While drug discovery has been established as a domain where algorithmic involvement can create substantial efficiency gains, other aspects of the pharmaceutical development process such as non-clinical and clinical safety are of critical importance towards creating patient value. This talk will explore the drug development process, the concepts of non-clinical safety with a particular focus on toxicologic pathology, and recent insights on building ML pipelines and foundation models therein.
There has been a significant amount of interest in artificial intelligence in the pharmaceutical industry, particularly with respect to drug discovery. While drug discovery has been established as a domain where algorithmic involvement can create substantial efficiency gains, other aspects of the pharmaceutical development process such as non-clinical and clinical safety are of critical importance towards creating patient value. This talk will explore the drug development process, the concepts of non-clinical safety with a particular focus on toxicologic pathology, and recent insights on building ML pipelines and foundation models therein.
Speaker Bio:
Dr Arijit Patra is a Senior Principal Scientist at UCB Biopharma UK and a Honorary Senior Lecturer (Associate Prof) at the University of Glasgow. He holds a PhD in machine learning for healthcare imaging from the University of Oxford, where he was a Rhodes Scholar (India & Exeter, 2016). Prior to that, he completed a dual degree in Mechanical Engineering from the Indian Institute of Technology (IIT) at Kharagpur, India. He has also been associated with AstraZeneca, Shell, Microsoft Research and CSIR-South Africa at various points in his career and has been actively involved in the AI4SG (AI for Social Good) community. He has authored several publications around machine learning and medical imaging and is a reviewer for multiple peer reviewed venues such as NeurIPS, ICML, MICCAI and several journals. Arijit has been appointed as a Rising Leaders fellow of the Aspen Institute UK, and as an International Strategy Forum fellow in 2024.
Dr Arijit Patra is a Senior Principal Scientist at UCB Biopharma UK and a Honorary Senior Lecturer (Associate Prof) at the University of Glasgow. He holds a PhD in machine learning for healthcare imaging from the University of Oxford, where he was a Rhodes Scholar (India & Exeter, 2016). Prior to that, he completed a dual degree in Mechanical Engineering from the Indian Institute of Technology (IIT) at Kharagpur, India. He has also been associated with AstraZeneca, Shell, Microsoft Research and CSIR-South Africa at various points in his career and has been actively involved in the AI4SG (AI for Social Good) community. He has authored several publications around machine learning and medical imaging and is a reviewer for multiple peer reviewed venues such as NeurIPS, ICML, MICCAI and several journals. Arijit has been appointed as a Rising Leaders fellow of the Aspen Institute UK, and as an International Strategy Forum fellow in 2024.
- 19 - 19 December,2025
- 11:30 am - 01:00 pm
- Bharti 105